Rise and shine, everyone, another busy day is on the way. The Pharmalot campus, for instance, is buzzing as the shortest of short people leaves for the local schoolhouse and our official mascot is snoozing about. As for us, we are engaged in our usual routine of sipping cups of hot stimulation and foraging for interesting items. Meanwhile, here is your menu of tidbits to get started. Hope you conquer the world today and, of course, do stay in touch. …

Insys Therapeutics (INSY) agreed to pay $225 million to settle criminal and civil investigations into marketing practices of using kickbacks to persuade doctors to prescribe its Subsys painkiller, which contains fentanyl, a powerful and addictive opioid, STAT says. As part of the deal, an Insys subsidiary will plead guilty to five counts of mail fraud, while the company will pay a $2 million fine, $28 million in forfeitures, and $195 million to settle charges of violating the federal False Claims Act, which involves defrauding the federal government. The company must also sell the painkiller within a year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy